Feb. 16, 2018--Women who work as cleaners or regularly use cleaning sprays or other cleaning products at home appear to experience a greater decline in lung function over time than women who do not clean, according to new research published online in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine.
In "Cleaning at Home and at Work in Relation to Lung Function Decline and Airway Obstruction," researchers at the University of Bergen in Norway analyzed data from 6,235 participants in the European Community Respiratory Health Survey. The participants, whose average age was 34 when they enrolled, were followed for more than 20 years.
"While the short-term effects of cleaning chemicals on asthma are becoming increasingly well documented, we lack knowledge of the long-term impact," said senior study author Cecile Svanes, MD, PhD, a professor at the university's Centre for International Health. "We feared that such chemicals, by steadily causing a little damage to the airways day after day, year after year, might accelerate the rate of lung function decline that occurs with age."
The study found that compared to women not engaged in cleaning:
- Forced expiratory volume in one second (FEV1), or the amount of air a person can forcibly exhale in one second, declined 3.6 milliliters (ml)/year faster in women who cleaned at home and 3.9 ml/year faster in women who worked as cleaners.
- Forced vital capacity (FVC), or the total amount of air a person can forcibly exhale, declined 4.3 ml/year faster in women who cleaned at home and 7.1 ml/year faster in women who worked as cleaners.
The authors found that the accelerated lung function decline in the women working as cleaners was "comparable to smoking somewhat less than 20 pack- years."
That level of lung impairment was surprising at first, said lead study author Øistein Svanes, a doctoral student also at the Department for Clinical Science. "However, when you think of inhaling small particles from cleaning agents that are meant for cleaning the floor and not your lungs, maybe it is not so surprising after all."
The authors speculate that the decline in lung function is attributable to the irritation that most cleaning chemicals cause on the mucous membranes lining the airways, which over time results in persistent changes in the airways and airway remodeling.
The study did not find that the ratio of FEV1 to FVC declined more rapidly in women who cleaned than in those who did not. The metric is used when diagnosing and monitoring patients with chronic obstructive pulmonary disease, or COPD. The study did find that asthma was more prevalent in women who cleaned at home (12.3 percent) or at work (13.7 percent) compared to those who did not clean (9.6 percent).
The study also did not find that men who cleaned, either at home or at work, experienced greater decline in FEV1 or FVC than men who did not.
The researchers took into account factors that might have biased the results, including smoking history, body mass index and education.
Study limitations include the fact that the study population included very few women who did not clean at home or work. These women, the authors wrote, might "constitute a selected socioeconomic group." The number of men who worked as occupational cleaners was also small, and their exposure to cleaning agents was likely different from that of women working as cleaning professionals.
"The take home message of this study is that in the long run cleaning chemicals very likely cause rather substantial damage to your lungs," Øistein Svanes said. "These chemicals are usually unnecessary; microfiber cloths and water are more than enough for most purposes."
He added that public health officials should strictly regulate cleaning products and encourage producers to develop cleaning agents that cannot be inhaled.
Share via Twitter
"Study finds #lung function declines faster in women who clean at home or work than those who do not."
About the American Journal of Respiratory and Critical Care Medicine (AJRCCM):
The AJRCCM is a peer-reviewed journal published by the American Thoracic Society. The Journal takes pride in publishing the most innovative science and the highest quality reviews, practice guidelines and statements in pulmonary, critical care and sleep medicine. With an impact factor of 12.996, it is the highest ranked journal in pulmonology. Editor: Jadwiga Wedzicha, MD, professor of respiratory medicine at the National Heart and Lung Institute (Royal Brompton Campus), Imperial College London, UK.
About the American Thoracic Society:
Founded in 1905, the American Thoracic Society is the world's leading medical association dedicated to advancing pulmonary, critical care and sleep medicine. The Society's 15,000 members prevent and fight respiratory disease around the globe through research, education, patient care and advocacy. The ATS publishes three journals, the American Journal of Respiratory and Critical Care Medicine, the American Journal of Respiratory Cell and Molecular Biology and the Annals of the American Thoracic Society.
The ATS will hold its 2018 International Conference, May 18-23, in San Diego, California, where world-renowned experts will share the latest scientific research and clinical advances in pulmonary, critical care and sleep medicine.